Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.
Liberty Biopharma Stock Performance
The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12. The firm has a market cap of C$21.54 million and a P/E ratio of -12.66. The firm’s fifty day moving average price is C$2.00 and its 200 day moving average price is C$2.00.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Read More
- Five stocks we like better than Liberty Biopharma
- How to Evaluate a Stock Before BuyingÂ
- AMD is Down 35%. Now is the Time to Buy the Dip
- What is Forex and How Does it Work?
- Amazon Stands Tall: New Highs Are in Sight
- Do ETFs Pay Dividends? What You Need to Know
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.